•
Jun 30, 2023

AMN Healthcare Q2 2023 Earnings Report

AMN Healthcare's Q2 2023 financial results were announced, with revenue of $991 million and adjusted EPS of $2.38.

Key Takeaways

AMN Healthcare reported Q2 2023 consolidated revenue of $991.3 million, a 31% decrease from the prior year and 12% lower than the prior quarter. GAAP EPS was $1.55, and adjusted EPS was $2.38. The company is focused on technology enablement and strategic talent solutions.

Consolidated revenue for the quarter was $991.3 million, a 31% decrease from prior year.

Net income was $61 million, or $1.55 per diluted share.

Adjusted diluted EPS in the second quarter was $2.38.

The company spent $425 million year to date to repurchase 4.1 million shares of common stock.

Total Revenue
$991M
Previous year: $1.43B
-30.5%
EPS
$2.38
Previous year: $3.31
-28.1%
Gross Profit
$330M
Previous year: $460M
-28.2%
Cash and Equivalents
$7M
Previous year: $79M
-91.1%
Free Cash Flow
$171M
Previous year: $207M
-17.4%
Total Assets
$2.64B
Previous year: $3.01B
-12.1%

AMN Healthcare

AMN Healthcare

AMN Healthcare Revenue by Segment

Forward Guidance

Revenue in the third quarter of 2023 is expected to be 24-26% lower than prior year and 13-15% lower sequentially.